JP2008510828A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510828A5
JP2008510828A5 JP2007530127A JP2007530127A JP2008510828A5 JP 2008510828 A5 JP2008510828 A5 JP 2008510828A5 JP 2007530127 A JP2007530127 A JP 2007530127A JP 2007530127 A JP2007530127 A JP 2007530127A JP 2008510828 A5 JP2008510828 A5 JP 2008510828A5
Authority
JP
Japan
Prior art keywords
compound according
compound
group
methyl
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007530127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510828A (ja
JP4952943B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/030259 external-priority patent/WO2006026356A2/en
Publication of JP2008510828A publication Critical patent/JP2008510828A/ja
Publication of JP2008510828A5 publication Critical patent/JP2008510828A5/ja
Application granted granted Critical
Publication of JP4952943B2 publication Critical patent/JP4952943B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007530127A 2004-08-25 2005-08-25 HIV逆転写酵素のインヒビターとしてのS−トリアゾリルα−メルカプトアセトアニリド Active JP4952943B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60422004P 2004-08-25 2004-08-25
US60421904P 2004-08-25 2004-08-25
US60/604,219 2004-08-25
US60/604,220 2004-08-25
US68635105P 2005-05-31 2005-05-31
US60/686,351 2005-05-31
PCT/US2005/030259 WO2006026356A2 (en) 2004-08-25 2005-08-25 S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012000790A Division JP5457472B2 (ja) 2004-08-25 2012-01-05 HIV逆転写酵素のインヒビターとしてのS−トリアゾリルα−メルカプトアセトアニリド

Publications (3)

Publication Number Publication Date
JP2008510828A JP2008510828A (ja) 2008-04-10
JP2008510828A5 true JP2008510828A5 (US07794700-20100914-C00152.png) 2008-07-17
JP4952943B2 JP4952943B2 (ja) 2012-06-13

Family

ID=36000576

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530127A Active JP4952943B2 (ja) 2004-08-25 2005-08-25 HIV逆転写酵素のインヒビターとしてのS−トリアゾリルα−メルカプトアセトアニリド
JP2012000790A Active JP5457472B2 (ja) 2004-08-25 2012-01-05 HIV逆転写酵素のインヒビターとしてのS−トリアゾリルα−メルカプトアセトアニリド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012000790A Active JP5457472B2 (ja) 2004-08-25 2012-01-05 HIV逆転写酵素のインヒビターとしてのS−トリアゾリルα−メルカプトアセトアニリド

Country Status (32)

Country Link
US (8) US7947721B2 (US07794700-20100914-C00152.png)
EP (5) EP2402011B1 (US07794700-20100914-C00152.png)
JP (2) JP4952943B2 (US07794700-20100914-C00152.png)
KR (1) KR101241716B1 (US07794700-20100914-C00152.png)
CN (2) CN101817793B (US07794700-20100914-C00152.png)
AT (2) ATE528001T1 (US07794700-20100914-C00152.png)
AU (2) AU2005280130C9 (US07794700-20100914-C00152.png)
BR (2) BRPI0514630B8 (US07794700-20100914-C00152.png)
CA (1) CA2578068C (US07794700-20100914-C00152.png)
CY (2) CY1112221T1 (US07794700-20100914-C00152.png)
DK (1) DK2135608T3 (US07794700-20100914-C00152.png)
EA (2) EA015846B1 (US07794700-20100914-C00152.png)
EC (1) ECSP077322A (US07794700-20100914-C00152.png)
ES (2) ES2380604T3 (US07794700-20100914-C00152.png)
FR (1) FR16C0031I2 (US07794700-20100914-C00152.png)
HK (1) HK1133582A1 (US07794700-20100914-C00152.png)
HR (1) HRP20130075T1 (US07794700-20100914-C00152.png)
HU (1) HUS1600034I1 (US07794700-20100914-C00152.png)
IL (3) IL181523A (US07794700-20100914-C00152.png)
IN (1) IN2014CN03762A (US07794700-20100914-C00152.png)
LT (1) LTC2135608I2 (US07794700-20100914-C00152.png)
LU (1) LU93169I2 (US07794700-20100914-C00152.png)
ME (1) ME01512B (US07794700-20100914-C00152.png)
MX (1) MX2007002236A (US07794700-20100914-C00152.png)
NL (1) NL300825I2 (US07794700-20100914-C00152.png)
NZ (2) NZ553534A (US07794700-20100914-C00152.png)
PL (1) PL2135608T3 (US07794700-20100914-C00152.png)
PT (1) PT2135608E (US07794700-20100914-C00152.png)
RS (1) RS52632B (US07794700-20100914-C00152.png)
SG (2) SG155246A1 (US07794700-20100914-C00152.png)
SI (1) SI2135608T1 (US07794700-20100914-C00152.png)
WO (1) WO2006026356A2 (US07794700-20100914-C00152.png)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402011B1 (en) * 2004-08-25 2012-11-14 Ardea Biosciences, Inc. S-triazolyl alpha-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
ES2542153T3 (es) 2007-05-30 2015-07-31 F. Hoffmann-La Roche Ag Inhibidores no nucleósidos de la transcriptasa inversa
WO2009030996A1 (en) * 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
SI2217577T1 (sl) * 2007-11-27 2014-11-28 Ardea Biosciences, Inc. Nove spojine in sestavki ter metode uporabe
US8242154B2 (en) * 2008-09-04 2012-08-14 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
KR20110050708A (ko) 2008-09-04 2011-05-16 아디아 바이오사이언스즈 인크. 요산 수치를 조절하기 위한 화합물, 조성물 및 이들의 사용 방법
US8173690B2 (en) * 2008-09-04 2012-05-08 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
WO2010048592A1 (en) * 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
US20110244049A1 (en) * 2008-10-24 2011-10-06 Ardea Biosciences Inc. Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
EP2432468A2 (en) 2009-05-20 2012-03-28 Ardea Biosciences, Inc. Methods of modulating uric acid levels
CN102040546B (zh) * 2009-10-10 2014-10-15 台州市华南医化有限公司 一种4-环丙基-1-异硫氰基萘的制备方法及中间体4-环丙基-1-萘甲醛肟/卤化物
AU2011203708B2 (en) * 2010-01-08 2013-08-01 Ardea Biosciences, Inc. Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate, and uses thereof
WO2011126852A2 (en) 2010-03-30 2011-10-13 Ardea Biosciences, Inc. Treatment of gout
CA2802407C (en) 2010-06-15 2018-01-23 Ardea Biosciences, Inc. Treatment of gout and hyperuricemia
WO2011159840A2 (en) 2010-06-16 2011-12-22 Ardea Biosciences, Inc. Phenylthioacetate compounds, compositions and methods of use
AR081930A1 (es) 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
CN101899013B (zh) * 2010-07-12 2012-07-25 山东大学 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用
WO2012050589A1 (en) * 2010-10-15 2012-04-19 Ardea Biosciences, Inc. Methods for treating hyperuricemia and related diseases
MX2013007505A (es) 2010-12-30 2013-08-01 Ardea Biosciences Inc Formas polimorficas de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1 -il)-4h-1,2,4-triazol-3-iltio)acetico y usos de los mismos.
JP6025853B2 (ja) 2011-11-03 2016-11-16 アルデア バイオサイエンシーズ インク. 3,4−二置換ピリジン化合物、その使用方法、および、該化合物を含む組成物
AR091651A1 (es) 2012-07-03 2015-02-18 Ardea Biosciences Inc Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico
CN105263913B (zh) * 2013-06-14 2017-12-15 广东东阳光药业有限公司 硫代1,2,4‑三唑衍生物及其制备方法
CN103524440B (zh) * 2013-10-15 2015-09-09 苏州鹏旭医药科技有限公司 痛风治疗药Lesinurad的制备方法及Lesinurad中间体
EP3071554B1 (en) * 2013-11-22 2018-10-03 Crystal Pharmatech Co., Ltd. Crystalline forms of lesinurad
CN104557748A (zh) * 2014-01-25 2015-04-29 广东东阳光药业有限公司 硫代-1,2,4-三唑衍生物的新的固体形态
CN105315218A (zh) * 2014-07-17 2016-02-10 天津药物研究院 一种制备lesinurad中间体1-萘基三唑硫酮的方法
CN104326998B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑丙二酸类化合物、其制备方法及用途
CN104341362B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104341361B (zh) * 2014-10-27 2017-01-11 张远强 一种腈基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104327000B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104326993B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104311498B (zh) * 2014-10-27 2016-04-06 张远强 烷氧基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104341363B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104370841B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104370842B (zh) * 2014-10-27 2016-07-13 张远强 苯基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
EP3112334A1 (en) 2015-06-29 2017-01-04 DPx Fine Chemicals Austria GmbH & CoKG Process for manufacturing 1-cyclopropyl-naphthalenes
CN104987311A (zh) * 2015-06-30 2015-10-21 安徽万邦医药科技有限公司 一种[4-(4-环丙基萘-1-基)-5-硝基- 4h-[1,2,4]三唑-3-基硫烷基]-乙酸乙酯的制备方法及其中间体(5-硝基-4h-[1,2,4]三唑-3-基硫基)-乙酸乙酯
CN105017168A (zh) * 2015-07-01 2015-11-04 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
CN105153056A (zh) * 2015-07-01 2015-12-16 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
WO2017036884A1 (en) 2015-08-28 2017-03-09 Sandoz Ag A lesinurad, free form / lesinurad ethyl ester co-crystal
CN105566237B (zh) * 2016-03-01 2018-05-18 山东大学 一种治疗痛风的三唑巯乙酸类化合物的制备方法
US10633351B2 (en) 2016-06-17 2020-04-28 Medshine Discovery Inc. Halogenated compound and axially chiral isomer thereof
EP3281941B1 (en) 2016-08-11 2019-07-24 Zentiva K.S. Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
EP3372592A1 (en) 2017-03-07 2018-09-12 Zentiva, k.s. Solid forms of lesinurad amine salts
US10351537B2 (en) * 2017-03-10 2019-07-16 Apotex Inc. Processes for the preparation of lesinurad and intermediates thereof
EP3315494A1 (en) 2017-04-19 2018-05-02 Química Sintética, S.A. Amorphous form of lesinurad and processes for its preparation
CN108947919B (zh) 2017-05-17 2023-05-02 上海奥博生物医药股份有限公司 一种抗痛风药Lesinurad的新型制备方法及其关键中间体
WO2019001325A1 (zh) * 2017-06-28 2019-01-03 苏州科睿思制药有限公司 雷西纳得的晶型xv及其制备方法
EP3498697A1 (en) 2017-12-12 2019-06-19 Química Sintética, S.A. Novel salts and polymorphs of lesinurad
WO2022249788A1 (ja) 2021-05-28 2022-12-01 住友化学株式会社 シクロアルキルブロミドの製造方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006A (en) * 1841-03-16 Clamp for crimping leather
US2008A (en) * 1841-03-18 Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
US2009A (en) * 1841-03-18 Improvement in machines for boring war-rockets
US226186A (en) 1880-04-06 Car-coupling
JPS5641637B2 (US07794700-20100914-C00152.png) 1973-11-26 1981-09-29
US6832996B2 (en) * 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
JPH07215940A (ja) 1994-01-27 1995-08-15 Torii Yakuhin Kk 抗ウイルス活性を有する化合物
US6245817B1 (en) * 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
EP0910565A1 (en) 1997-02-14 1999-04-28 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
JPH10243033A (ja) * 1997-02-28 1998-09-11 Oki Electric Ind Co Ltd 復調装置
BRPI9909191B8 (pt) * 1998-03-27 2021-07-06 Janssen Pharmaceutica Nv derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende
KR20010080402A (ko) 1998-11-12 2001-08-22 추후기재 Crf 수용체 길항제 및 그와 관련된 방법
AU2217200A (en) * 1998-12-23 2000-07-12 Neurogen Corporation 2-amino-9-alkylpurines: gaba brain receptor ligands
DE69939749D1 (de) * 1998-12-25 2008-11-27 Shionogi & Co Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften
US6593077B2 (en) * 1999-03-22 2003-07-15 Special Materials Research And Technology, Inc. Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate
PL364658A1 (en) 2001-03-02 2004-12-13 Smithkline Beecham Corporation Benzophenones as inhibitors of reverse transcriptase
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
WO2003097047A1 (en) 2002-05-13 2003-11-27 Eli Lilly And Company Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
AU2003295324B2 (en) 2002-08-23 2008-08-28 Ardea Biosciences,Inc. Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
CA2513527C (en) 2003-02-07 2012-08-14 Janssen Pharmaceutica N.V. Pyrimidine derivatives for the prevention of hiv infection
EA009734B1 (ru) 2003-09-25 2008-02-28 Янссен Фармацевтика Н.В. Производные пурина, ингибирующие репликацию вич
US20080031901A1 (en) * 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
US7517998B2 (en) 2004-06-01 2009-04-14 Boehringer Ingelheim International Gmbh Non nucleoside reverse transcriptase inhibitors
EP2402011B1 (en) 2004-08-25 2012-11-14 Ardea Biosciences, Inc. S-triazolyl alpha-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
SI2217577T1 (sl) * 2007-11-27 2014-11-28 Ardea Biosciences, Inc. Nove spojine in sestavki ter metode uporabe
WO2010048592A1 (en) 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
US20110244049A1 (en) 2008-10-24 2011-10-06 Ardea Biosciences Inc. Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
TWM377707U (en) 2009-09-16 2010-04-01 Nat Energy Technology Co Ltd Assembly of power supply

Similar Documents

Publication Publication Date Title
JP2008510828A5 (US07794700-20100914-C00152.png)
JP2010501478A5 (US07794700-20100914-C00152.png)
JP2006505543A5 (US07794700-20100914-C00152.png)
JP2019104748A5 (US07794700-20100914-C00152.png)
CA2578068A1 (en) S-triazolyl .alpha.-mercaptoacetanildes as inhibitors of hiv reverse transcriptase
JP2010511721A5 (US07794700-20100914-C00152.png)
JP2009529540A5 (US07794700-20100914-C00152.png)
JP2011526917A5 (US07794700-20100914-C00152.png)
JP2008535903A5 (US07794700-20100914-C00152.png)
JP2007534702A5 (US07794700-20100914-C00152.png)
JP2005523922A5 (US07794700-20100914-C00152.png)
JP2013537203A5 (US07794700-20100914-C00152.png)
JP2008546770A5 (US07794700-20100914-C00152.png)
JP2008533191A5 (US07794700-20100914-C00152.png)
JP2006515858A5 (US07794700-20100914-C00152.png)
JP2006507355A5 (US07794700-20100914-C00152.png)
JP2005053931A5 (US07794700-20100914-C00152.png)
JP2009515988A5 (US07794700-20100914-C00152.png)
JP2009520695A5 (US07794700-20100914-C00152.png)
JP2005507918A5 (US07794700-20100914-C00152.png)
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2009501745A5 (US07794700-20100914-C00152.png)
JP2009522364A5 (US07794700-20100914-C00152.png)
JP2013502441A5 (US07794700-20100914-C00152.png)
JP2009539943A5 (US07794700-20100914-C00152.png)